Research on drug rediscovery and optimization of IBD therapies, with a specific focus on thiopurines and its metabolism.
The second research line focusses on non-invasive biomarkers to detect and follow-up gastrointestinal diseases (like IBD, dysplasia, colon cancer and NEC)
